Literature DB >> 30844328

Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection.

Yuji Ishida1,2, Masakazu Kakuni2, Bo-Ram Bang1, Go Sugahara1,2, Daryl T-Y Lau3, Chise Tateno-Mukaidani2, Meng Li4, Michael Gale5, Takeshi Saito1,6.   

Abstract

Interferons (IFNs) suppress viral infection through the induction of >400 interferon-stimulated genes (ISGs). Among ISGs, IFN-induced protein with tetratricopeptide repeats (IFITs) is one of the most potent and well-characterized ISGs. IFIT family consists of 4 cluster genes. It has been suggested that the antiviral action of each IFIT employs distinct mechanisms. In addition, it has been shown that each IFIT exhibits its antiviral properties partially in a pathogen-specific manner. To date, the expression profile of IFITs in the liver, as well as the antiviral potency of the individual IFITs in the regulation of hepatitis C virus (HCV) infection, is not yet fully defined. Our previous study found that the expression of hepatic IFITs is well correlated with the outcome of IFN-based antiviral therapy. This study explored the significance of each IFIT in the suppression of HCV. Our in vitro and in vivo studies with humanized liver chimeric mouse system revealed that IFIT1, 2, and 3/4 play an important role in the suppression of HCV. In addition, our in vitro experiment found that all IFITs possess a comparable anti-HCV potency. Follow-up studies collectively indicated that IFITs suppress HCV likely through 2 distinct mechanisms: (1) inhibition of internal ribosome entry site-dependent viral protein translation initiation complex according to experiments with bicistronic reporter assay as well as confocal microscopic analyses and (2) sequestration of viral genome based on an experiment using replication defective viral genome. In conclusion, our study defined the importance of IFITs in the regulation of HCV and also suggested the multifaceted antiviral actions.

Entities:  

Keywords:  IFN-induced protein with tetratricopeptide repeats; hepatitis C virus; humanized liver chimeric mice; interferon stimulated genes

Mesh:

Substances:

Year:  2019        PMID: 30844328      PMCID: PMC6441290          DOI: 10.1089/jir.2018.0103

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  63 in total

1.  Spontaneous resolution of chronic hepatitis C virus infection: are we missing something?

Authors:  Georg M Lauer; Arthur Y Kim
Journal:  Clin Infect Dis       Date:  2006-02-28       Impact factor: 9.079

2.  Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

Authors:  Masao Honda; Akito Sakai; Tatsuya Yamashita; Yasunari Nakamoto; Eishiro Mizukoshi; Yoshio Sakai; Taro Yamashita; Mikiko Nakamura; Takayoshi Shirasaki; Katsuhisa Horimoto; Yasuhito Tanaka; Katsushi Tokunaga; Masashi Mizokami; Shuichi Kaneko
Journal:  Gastroenterology       Date:  2010-04-29       Impact factor: 22.682

3.  HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.

Authors:  Emmanuel Thomas; Veronica D Gonzalez; Qisheng Li; Ankit A Modi; Weiping Chen; Mazen Noureddin; Yaron Rotman; T Jake Liang
Journal:  Gastroenterology       Date:  2012-01-13       Impact factor: 22.682

4.  Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion.

Authors:  Sukanya Raghuraman; Heiyoung Park; William O Osburn; Emily Winkelstein; Brian R Edlin; Barbara Rehermann
Journal:  J Infect Dis       Date:  2012-01-31       Impact factor: 5.226

Review 5.  Interferon-induced Ifit proteins: their role in viral pathogenesis.

Authors:  Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

6.  Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice.

Authors:  Yuji Ishida; Chihiro Yamasaki; Ami Yanagi; Yasumi Yoshizane; Kazuyuki Fujikawa; Koichi Watashi; Hiromi Abe; Takaji Wakita; C Nelson Hayes; Kazuaki Chayama; Chise Tateno
Journal:  Am J Pathol       Date:  2015-03-17       Impact factor: 4.307

7.  ISG56 and IFITM1 proteins inhibit hepatitis C virus replication.

Authors:  Amit Raychoudhuri; Shubham Shrivastava; Robert Steele; Hangeun Kim; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

8.  Lack of response to exogenous interferon-alpha in the liver of chimpanzees chronically infected with hepatitis C virus.

Authors:  Robert E Lanford; Bernadette Guerra; Catherine B Bigger; Helen Lee; Deborah Chavez; Kathleen M Brasky
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

9.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

10.  Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins.

Authors:  Yazan M Abbas; Andreas Pichlmair; Maria W Górna; Giulio Superti-Furga; Bhushan Nagar
Journal:  Nature       Date:  2013-01-13       Impact factor: 49.962

View more
  2 in total

1.  Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection.

Authors:  Anna Paola Carreca; Massimiliano Gaetani; Rosalia Busà; Maria Giovanna Francipane; Maria Rita Gulotta; Ugo Perricone; Gioacchin Iannolo; Giovanna Russelli; Claudia Carcione; Pier Giulio Conaldi; Ester Badami
Journal:  Viruses       Date:  2022-07-14       Impact factor: 5.818

2.  Ifit1 regulates norovirus infection and enhances the interferon response in murine macrophage-like cells.

Authors:  Harriet V Mears; Edward Emmott; Yasmin Chaudhry; Myra Hosmillo; Ian G Goodfellow; Trevor R Sweeney
Journal:  Wellcome Open Res       Date:  2019-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.